Tissue Regenix Group Share Price | |
---|---|
Price | 68.50 |
Bid | 0.00 |
Ask | 0.00 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 68.50 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 70.57m |
Market Capitalisation | £48.34m |
Market Size | 2,000 |
52 Week High | 71.50 |
52 Week High Date | 26-Feb-2024 |
52 Week Low | 0.54 |
52 Week Low Date | 29-Mar-2023 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | -20.64504 |
Earnings | -3.317988 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
15-Mar-24 | 12:10:04 | 67.5775 | 37,005 | Unknown* | 67.00 | 70.00 | 25.01k | O Ordinary Delayed publication Historical |
18-Mar-24 | 15:55:53 | 67.30 | 72 | Sell* | 67.00 | 70.00 | 48.46 | O Ordinary |
18-Mar-24 | 15:20:28 | 67.30 | 13 | Sell* | 67.00 | 70.00 | 8.75 | O Ordinary |
18-Mar-24 | 15:04:49 | 68.70 | 713 | Buy* | 67.00 | 70.00 | 489.83 | O Ordinary |
18-Mar-24 | 14:48:02 | 68.70 | 4,000 | Buy* | 67.00 | 70.00 | 2,748 | O Ordinary |
18-Mar-24 | 12:44:36 | 67.55 | 14,824 | Unknown* | 67.00 | 70.00 | 10.01k | O Ordinary Delayed publication |
18-Mar-24 | 13:25:16 | 68.70 | 285 | Buy* | 67.00 | 70.00 | 195.80 | O Ordinary |
18-Mar-24 | 12:22:13 | 67.55 | 178 | Sell* | 67.00 | 70.00 | 120.24 | O Ordinary |
18-Mar-24 | 10:11:38 | 68.75 | 400 | Buy* | 67.00 | 70.00 | 275.00 | O Ordinary |
18-Mar-24 | 10:10:08 | 67.30 | 41 | Sell* | 67.00 | 70.00 | 27.59 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
15-Sep-23 | 15-Sep-23 | Buy | Brian Phillips held the position of Independent Non-Executive Director at the time of this trade.Brian Phillips | 54.00 | GBX | 6,773 | 160,001 |
05-Apr-23 | 04-Apr-23 | Buy | David Cocke held the position of CFO at the time of this trade.David Cocke | 0.56 | GBX | 928,570 | 7,120,570 |
05-Apr-23 | 04-Apr-23 | Buy | David Cocke held the position of CFO at the time of this trade.David Cocke | 0.57 | GBX | 500,000 | 7,120,570 |
05-Apr-23 | 04-Apr-23 | Buy | Daniel Lee held the position of CEO at the time of this trade.Daniel Lee | 0.56 | GBX | 928,570 | 8,690,770 |
05-Apr-23 | 04-Apr-23 | Buy | Daniel Lee held the position of CEO at the time of this trade.Daniel Lee | 0.57 | GBX | 500,000 | 8,690,770 |
Tissue Regenix Group is a pioneering, international medical technology company, focusing on the development of regenerative products.